| Q30488406 | A pilot randomized clinical safety study of sonothrombolysis augmentation with ultrasound-activated perflutren-lipid microspheres for acute ischemic stroke |
| Q30407045 | A pragmatic approach to sonothrombolysis in acute ischaemic stroke: the Norwegian randomised controlled sonothrombolysis in acute stroke study (NOR-SASS). |
| Q97905035 | A thrombolytic therapy using diagnostic ultrasound combined with RGDS-targeted microbubbles and urokinase in a rabbit model |
| Q51093211 | Absence of biological damage from prolonged exposure to intravascular ultrasound: a swine model. |
| Q30500844 | Acousto-mechanical and thermal properties of clotted blood. |
| Q89975772 | Advances in Sonothrombolysis Techniques Using Piezoelectric Transducers |
| Q50987458 | An uncovered risk factor of sonothrombolysis: Substantial fluctuation of ultrasound transmittance through the human skull. |
| Q30443734 | Application of cavitation promoting surfaces in management of acute ischemic stroke |
| Q30500234 | Arrhenius temperature dependence of in vitro tissue plasminogen activator thrombolysis. |
| Q51025365 | Cavitational mechanisms in ultrasound-accelerated fibrinolysis. |
| Q40411191 | Continuous monitoring of middle cerebral artery recanalization with transcranial color-coded sonography and Levovist |
| Q30502209 | Correlation of cavitation with ultrasound enhancement of thrombolysis |
| Q47422438 | Dependence of optimal seed bubble size on pressure amplitude at therapeutic pressure levels |
| Q36984632 | Diagnostic Ultrasound High Mechanical Index Impulses Restore Microvascular Flow in Peripheral Arterial Thromboembolism |
| Q39748618 | Effect of Thrombus Composition and Viscosity on Sonoreperfusion Efficacy in a Model of Micro-Vascular Obstruction |
| Q30484441 | Effect of low frequency ultrasound on combined rt-PA and eptifibatide thrombolysis in human clots |
| Q34558731 | Effectiveness of lipid microbubbles and ultrasound in declotting thrombosis |
| Q36058462 | Healing sound: the use of ultrasound in drug delivery and other therapeutic applications |
| Q50471651 | Hemorrhage near fetal rat bone exposed to pulsed ultrasound. |
| Q30480838 | In vitro microscopic imaging of enhanced thrombolysis with 120-kHz ultrasound in a human clot model |
| Q84028973 | In vitro sonothrombolysis of human blood clots with BR38 microbubbles |
| Q78431112 | In vitro thrombolysis enhanced by standing and travelling ultrasound wave fields |
| Q53589220 | In vivo thrombolysis with targeted microbubbles loading tissue plasminogen activator in a rabbit femoral artery thrombus model. |
| Q52882249 | Inertial Cavitation Ultrasound with Microbubbles Improves Reperfusion Efficacy When Combined with Tissue Plasminogen Activator in an In Vitro Model of Microvascular Obstruction. |
| Q73408551 | Inertial cavitation dose and hemolysis produced in vitro with or without Optison |
| Q92499240 | Intra-clot Microbubble-Enhanced Ultrasound Accelerates Catheter-Directed Thrombolysis for Deep Vein Thrombosis: A Clinical Study |
| Q30459834 | Microbubble mediated thrombus dissolution with diagnostic ultrasound for the treatment of chronic venous thrombi |
| Q48161704 | Microbubble potentiated transcranial duplex ultrasound enhances IV thrombolysis in acute stroke |
| Q38628295 | Microbubbles and UltraSound-accelerated Thrombolysis (MUST) for peripheral arterial occlusions: protocol for a phase II single-arm trial |
| Q30380882 | Microfluidic manufacture of rt-PA -loaded echogenic liposomes. |
| Q34134988 | Model processes and cavitation indicators for a quantitative description of an ultrasonic cleaning vessel: Part II--multivariate data analysis |
| Q30367915 | Molecular mechanisms of the effect of ultrasound on the fibrinolysis of clots. |
| Q30474719 | Noninvasive, transient and selective blood-brain barrier opening in non-human primates in vivo. |
| Q30441143 | Numerical study of a simple transcranial focused ultrasound system applied to blood-brain barrier opening. |
| Q30478402 | Passive cavitation imaging with ultrasound arrays |
| Q30452908 | Passive imaging with pulsed ultrasound insonations |
| Q30471810 | Potentiating intra-arterial sonothrombolysis for acute ischemic stroke by the addition of the ultrasound contrast agents (Optison™ & SonoVue(®)) |
| Q38360868 | Prevention of arteriovenous shunt occlusion using microbubble and ultrasound mediated thromboprophylaxis |
| Q30494419 | Pulsed high-intensity focused ultrasound enhances thrombolysis in an in vitro model |
| Q30479878 | Recanalization Therapies in Acute Ischemic Stroke: Pharmacological Agents, Devices, and Combinations |
| Q30712454 | Review of stroke thrombolytics |
| Q81419392 | Safety and efficacy of the sonographic acceleration of the middle cerebral artery recanalization: results of the pilot thrombotripsy study |
| Q27303116 | Shaken and stirred: mechanisms of ultrasound-enhanced thrombolysis |
| Q39984748 | Simulation of intracranial acoustic fields in clinical trials of sonothrombolysis. |
| Q26781198 | Sonothrombolysis |
| Q48178241 | Sonothrombolysis in ischemic stroke |
| Q30438824 | Spatial specificity and sensitivity of passive cavitation imaging for monitoring high-intensity focused ultrasound thermal ablation in ex vivo bovine liver. |
| Q80167172 | Stability of alteplase in presence of cavitation |
| Q52546636 | The disappearance of ultrasound contrast bubbles: observations of bubble dissolution and cavitation nucleation. |
| Q81119576 | The effect of 40 kHz ultrasound on tissue plasminogen activator-induced clot lysis in three in vitro models |
| Q47966546 | Therapeutic application of contrast ultrasound in ST elevation myocardial infarction: Role in coronary thrombosis and microvascular obstruction. |
| Q37136215 | Therapeutic opportunities in biological responses of ultrasound |
| Q34540070 | Therapeutic ultrasound: its application in drug delivery |
| Q30485761 | Tissue plasminogen activator concentration dependence of 120 kHz ultrasound-enhanced thrombolysis. |
| Q30416699 | Tissue plasminogen activator-based clot busting: Controlled delivery approaches |
| Q47931181 | Tissue plasminogen activator-based nanothrombolysis for ischemic stroke |
| Q47093814 | Ultrasound Mediated Microbubbles Destruction Augmented Sonolysis: An In Vitro and In Vivo Study |
| Q52943200 | Ultrasound and Intra-Clot Microbubbles Enhanced Catheter-Directed Thrombolysis in Vitro and in Vivo. |
| Q30487765 | Ultrasound attenuation estimation using backscattered echoes from multiple sources |
| Q78014170 | Ultrasound enhancement of fibrinolysis at frequencies of 27 to 100 kHz |
| Q90804583 | Ultrasound with Microbubble Contrast Agent and Urokinase for Thrombosis |
| Q90277042 | Ultrasound-Responsive Cavitation Nuclei for Therapy and Drug Delivery |
| Q31011806 | Ultrasound-assisted thrombolysis in acute ischemic stroke |
| Q44238112 | Ultrasound-assisted thrombolysis with streptokinase improves thrombus resolution with minimal distal embolisation |
| Q30479478 | Ultrasound-enhanced thrombolysis using Definity as a cavitation nucleation agent. |
| Q30480851 | Ultrasound-enhanced thrombolysis with tPA-loaded echogenic liposomes |
| Q30492023 | Ultrasound-enhanced tissue plasminogen activator thrombolysis in an in vitro porcine clot model |
| Q30499410 | Ultrasound-induced thermal elevation in clotted blood and cranial bone |
| Q30438336 | Ultrasound-mediated drug delivery for cardiovascular disease. |
| Q50250119 | Vascular effects induced by combined 1-MHz ultrasound and microbubble contrast agent treatments in vivo |